Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 6 studies | 44% ± 22% | |
retinal ganglion cell | 4 studies | 46% ± 24% |
Insufficient scRNA-seq data for expression of RXRG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 83% | 843.08 | 2186 / 2642 | 74% | 8.41 | 519 / 705 |
thymus | 29% | 56.67 | 189 / 653 | 76% | 106.11 | 461 / 605 |
skin | 21% | 41.03 | 373 / 1809 | 80% | 77.35 | 378 / 472 |
muscle | 100% | 1569.89 | 801 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 19.16 | 70 / 80 |
heart | 74% | 270.55 | 638 / 861 | 0% | 0 | 0 / 0 |
lung | 60% | 193.00 | 347 / 578 | 8% | 0.66 | 89 / 1155 |
intestine | 64% | 274.80 | 618 / 966 | 1% | 0.21 | 7 / 527 |
esophagus | 62% | 296.96 | 899 / 1445 | 1% | 0.05 | 2 / 183 |
adipose | 58% | 216.24 | 697 / 1204 | 0% | 0 | 0 / 0 |
ovary | 21% | 46.41 | 38 / 180 | 28% | 6.31 | 119 / 430 |
adrenal gland | 11% | 27.54 | 29 / 258 | 33% | 6.71 | 77 / 230 |
bladder | 43% | 134.05 | 9 / 21 | 2% | 0.35 | 9 / 504 |
pancreas | 15% | 31.05 | 50 / 328 | 25% | 2.34 | 45 / 178 |
breast | 38% | 107.34 | 174 / 459 | 2% | 0.13 | 17 / 1118 |
prostate | 33% | 90.58 | 82 / 245 | 2% | 0.10 | 9 / 502 |
stomach | 30% | 103.87 | 107 / 359 | 2% | 0.09 | 5 / 286 |
uterus | 18% | 47.46 | 30 / 170 | 12% | 3.38 | 54 / 459 |
blood vessel | 15% | 40.34 | 205 / 1335 | 0% | 0 | 0 / 0 |
liver | 1% | 2.58 | 3 / 226 | 12% | 1.59 | 47 / 406 |
spleen | 5% | 7.68 | 13 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.09 | 1 / 45 |
kidney | 1% | 2.54 | 1 / 89 | 0% | 0.03 | 4 / 901 |
peripheral blood | 1% | 1.38 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032526 | Biological process | response to retinoic acid |
GO_0048856 | Biological process | anatomical structure development |
GO_0048384 | Biological process | retinoic acid receptor signaling pathway |
GO_0030154 | Biological process | cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0043401 | Biological process | steroid hormone receptor signaling pathway |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0008270 | Molecular function | zinc ion binding |
GO_0044323 | Molecular function | retinoic acid-responsive element binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
Gene name | RXRG |
Protein name | Retinoic acid receptor RXR (Nuclear receptor subfamily 2 group B member) Retinoic acid receptor RXR-gamma Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma) |
Synonyms | NR2B3 |
Description | FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid (By similarity). . FUNCTION: Receptor for retinoic acid that acts as a transcription factor. Forms homo- or heterodimers with retinoic acid receptors (rars) and binds to target response elements in response to their ligands, all-trans or 9-cis retinoic acid, to regulate gene expression in various biological processes. .; FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. . FUNCTION: Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. . |
Accessions | A0A087WZ88 ENST00000359842.10 F1D8Q7 P48443 ENST00000619224.1 F1T097 |